Foundational Science and Mechanisms of Disease

426 questions

Question 61Question →

A 16-year-old girl is brought to the clinic by her parents for a follow-up examination. She has a history of mild intellectual disability, truncal obesity, and obsessive food-seeking behavior. As an infant, she exhibited severe central hypotonia and poor feeding that required temporary nasogastric tube support. Physical examination today reveals a body mass index (BMI) of 34 kg/m² along with a narrow biparietal diameter, almond-shaped eyes, and small hands and feet.

To confirm the clinically suspected diagnosis, targeted molecular genetic testing is performed. DNA methylation analysis of the 15q11-q13 region is abnormal, showing an exclusively maternal methylation pattern. Subsequent high-resolution chromosomal microarray analysis demonstrates no evidence of genomic microdeletions or duplications across the genome.

Which of the following is the most likely underlying genetic mechanism responsible for this patient's condition?

Show answer & explanation

Answer: Inheritance of two structurally intact homologous chromosomes from a single parent

Answer

The correct answer is the inheritance of two structurally intact homologous chromosomes from a single parent, describing maternal uniparental disomy.
The patient's clinical presentation is classic for Prader-Willi syndrome (PWS). The diagnosis is confirmed by abnormal DNA methylation analysis of the 15q11-q13 region, which shows only a maternally imprinted pattern, indicating an absence of functional paternally expressed genes. While the most common cause of PWS is a paternal microdeletion (approximately 70% of cases), this patient has a completely normal chromosomal microarray. Because microarrays detect copy number variations, a normal result explicitly rules out a deletion. The second most common cause of PWS (approximately 25-30% of cases) is maternal uniparental disomy (UPD). In maternal UPD, the offspring inherits two copies of chromosome 15 from the mother and zero copies from the father. Because both chromosomes are of maternal origin, they both carry the maternal imprint (which silences the genes critical for preventing PWS), leading to a complete absence of expression of these specific genes despite the chromosomes being structurally intact. Therefore, the inheritance of two structurally intact homologous chromosomes from a single parent is the correct mechanism.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's history and physical examination findings.
The combination of infantile hypotonia, childhood hyperphagia, truncal obesity, mild intellectual disability, and characteristic facies strongly points to Prader-Willi syndrome (PWS).
Recognizing the phenotype establishes the differential diagnosis and directs the interpretation of specific genetic tests.
2
Analyze the DNA methylation assay results.
The presence of an exclusively maternal methylation pattern at 15q11-q13 confirms the diagnosis of PWS by demonstrating the lack of a functional paternally imprinted allele.
Methylation testing is highly sensitive for PWS but does not identify the specific molecular mechanism (deletion, uniparental disomy, or imprinting center defect).
3
Integrate the chromosomal microarray results to deduce the specific genetic mechanism.
The microarray shows no genomic microdeletions. Therefore, the lack of paternal expression must be due to the presence of two maternal copies of chromosome 15 (maternal uniparental disomy).
Microarray analysis detects copy number variations. A normal result rules out the most common cause of PWS (paternal microdeletion), isolating uniparental disomy or an imprinting defect as the cause.

Key Concept

Molecular mechanisms and diagnostic test interpretation in Prader-Willi syndrome.
Question 62Question →

An otherwise healthy carpenter is evaluated at an urgent care center for a tender, erythematous, and fluctuant nodule on the left thigh. Vital signs are within normal limits. The clinician performs an incision and drainage, yielding frank pus. A Gram stain of the purulent material demonstrates Gram-positive cocci arranged in grape-like clusters. Subsequent bacterial culture isolates an organism that demonstrates resistance to oxacillin. Which of the following is the most likely molecular mechanism underlying this pathogen's antimicrobial resistance profile?

Show answer & explanation

Answer: Synthesis of a modified penicillin-binding protein

Answer

The correct answer is the synthesis of a modified penicillin-binding protein.
The clinical presentation of a purulent soft tissue infection with a Gram stain showing Gram-positive cocci in clusters is highly characteristic of a Staphylococcus aureus infection. Resistance to oxacillin indicates that this is a methicillin-resistant S. aureus (MRSA) strain. MRSA develops resistance to beta-lactamase-resistant penicillins (such as oxacillin, nafcillin, and methicillin) through the acquisition of the staphylococcal cassette chromosome mec (SCCmec), which contains the mecA gene. This gene encodes penicillin-binding protein 2a (PBP2a), a modified transpeptidase that has a significantly reduced affinity for beta-lactam antibiotics. This alteration allows the bacteria to maintain cell wall cross-linking and survive even in the presence of beta-lactam drugs.

Step-by-Step Solution

1
Identify the likely pathogen based on the clinical presentation and Gram stain.
A purulent skin infection yielding Gram-positive cocci in grape-like clusters strongly indicates Staphylococcus aureus.
Recognizing the pathogen is the first step in determining its characteristic resistance mechanisms.
2
Interpret the significance of the antimicrobial susceptibility results.
The organism is resistant to oxacillin, indicating it is a methicillin-resistant Staphylococcus aureus (MRSA) strain.
Oxacillin is a beta-lactamase-resistant penicillin used in laboratory testing to detect methicillin resistance.
3
Identify the molecular mechanism that confers oxacillin/methicillin resistance in this pathogen.
MRSA acquires the mecA gene, which encodes a variant penicillin-binding protein (PBP2a) with very low affinity for beta-lactam antibiotics.
This allows the bacteria to continue synthesizing its cell wall even when beta-lactam antibiotics are present.

Key Concept

Methicillin-resistant Staphylococcus aureus (MRSA) exhibits resistance to all beta-lactam antibiotics (except ceftaroline) through the acquisition of the mecA gene, which encodes a modified transpeptidase known as penicillin-binding protein 2a (PBP2a) that has decreased affinity for these drugs.
Question 63Question →

A 72-year-old retired teacher residing in an assisted living community is evaluated at the hospital for a 3-day history of chills, rust-colored sputum, and shortness of breath. Temperature is 38.9°C (102°F), blood pressure is 110/65 mmHg, and oxygen saturation is 91% on room air. Auscultation reveals bronchial breath sounds and crackles over the left lower lung fields. A sputum Gram stain demonstrates numerous neutrophils and lancet-shaped, Gram-positive diplococci. Empiric therapy is initiated, but susceptibility testing later indicates the isolated organism requires a high minimum inhibitory concentration (MIC) to penicillin G and ceftriaxone. Which of the following best describes the underlying molecular mechanism responsible for this pathogen's resistance profile?

Show answer & explanation

Answer: Structural modification of native transpeptidases resulting in decreased drug affinity

Answer

Structural modification of native transpeptidases resulting in decreased drug affinity
The patient is infected with Streptococcus pneumoniae, as indicated by the classic presentation of lobar pneumonia with rust-colored sputum and a sputum Gram stain showing lancet-shaped, Gram-positive diplococci. Penicillins and cephalosporins exert their bactericidal effect by binding to and inhibiting penicillin-binding proteins (PBPs), which are transpeptidases essential for bacterial cell wall peptidoglycan cross-linking. S. pneumoniae develops resistance to these beta-lactam antibiotics via the acquisition of mosaic PBP genes (primarily PBP 1a, 2b, and 2x) through natural transformation and homologous recombination. This genetic change results in the production of structurally modified transpeptidases that possess significantly decreased affinity for the drugs. Consequently, cell wall synthesis can continue even in the presence of the antibiotic.

Step-by-Step Solution

1
Identify the infecting pathogen from the clinical presentation and laboratory findings.
The pathogen is Streptococcus pneumoniae.
The patient has community-acquired pneumonia with rust-colored sputum, and the Gram stain shows lancet-shaped, Gram-positive diplococci, which is the classic description of S. pneumoniae.
2
Determine the molecular mechanism of resistance to penicillins and cephalosporins for this specific organism.
Alteration of penicillin-binding proteins (PBPs).
Unlike many other bacteria, S. pneumoniae does not produce beta-lactamases. Instead, it acquires mosaic genes via natural transformation that alter the structure of its PBPs (transpeptidases), reducing their affinity for beta-lactam antibiotics.

Key Concept

Mechanism of beta-lactam resistance in Streptococcus pneumoniae
Question 64Question →

A 68-year-old woman is evaluated in the intensive care unit for a new-onset fever and increased oxygen requirements. She was admitted 12 days ago for severe acute pancreatitis and was intubated on day 3 due to acute respiratory distress syndrome. Her temperature is 38.9°C (102°F), blood pressure is 105/65 mm Hg, and pulse is 112/min. Physical examination reveals coarse crackles at the right lung base. A chest radiograph shows a new right lower lobe infiltrate. Endotracheal aspirate cultures grow oxidase-positive, non-lactose fermenting Gram-negative bacilli. The isolate is initially reported as susceptible to cefepime, piperacillin-tazobactam, and imipenem. She is started on empiric intravenous imipenem-cilastatin. Five days later, her clinical condition deteriorates. Repeat respiratory cultures grow the same organism, but susceptibility testing now demonstrates resistance to imipenem; the isolate remains susceptible to cefepime and piperacillin-tazobactam. Which of the following is the most likely molecular mechanism underlying this pathogen's acquired resistance?

Show answer & explanation

Answer: Mutational loss of a specific outer membrane channel protein

Answer

Mutational loss of a specific outer membrane channel protein
The clinical vignette describes a patient with ventilator-associated pneumonia caused by Pseudomonas aeruginosa (an oxidase-positive, non-lactose fermenting Gram-negative bacillus). The pathogen initially responded to empiric imipenem-cilastatin but subsequently developed isolated resistance to imipenem while remaining susceptible to other antipseudomonal beta-lactams (cefepime and piperacillin-tazobactam). Imipenem requires a specific outer membrane channel protein, the OprD porin, to penetrate the Pseudomonas cell envelope. During treatment with imipenem, P. aeruginosa frequently undergoes mutational loss or downregulation of this OprD porin. Because cefepime and piperacillin-tazobactam utilize different porins and entry pathways, the selective loss of OprD confers isolated resistance to imipenem without affecting the organism's susceptibility to these other beta-lactam agents.

Step-by-Step Solution

1
Identify the infecting pathogen from the microbiologic description.
The organism is an oxidase-positive, non-lactose fermenting Gram-negative bacillus, which is characteristic of Pseudomonas aeruginosa.
Establishing the specific pathogen is required to understand its unique mechanisms of acquiring antimicrobial resistance.
2
Analyze the susceptibility profile change.
The organism developed isolated resistance to imipenem while remaining fully susceptible to cefepime and piperacillin-tazobactam.
Different resistance mechanisms create distinct phenotypic susceptibility patterns (antibiograms).
3
Correlate the acquired susceptibility pattern with the correct molecular mechanism.
Isolated imipenem resistance in Pseudomonas aeruginosa is almost exclusively caused by the mutational loss or downregulation of the OprD outer membrane porin.
Imipenem uniquely relies on the OprD porin to cross the outer membrane, whereas other beta-lactams utilize different entry pathways.

Key Concept

Molecular mechanisms of selective antimicrobial resistance in Pseudomonas aeruginosa
Question 65Question →

A 68-year-old man is evaluated in the intensive care unit for a new onset of fever and increased purulent respiratory secretions. He was admitted 14 days14\text{ days} ago for a perforated diverticulum requiring emergency exploratory laparotomy and has been dependent on mechanical ventilation since the procedure. His temperature is 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure is 90/60 mmHg90/60\text{ mmHg}, pulse is 118 beats/min118\text{ beats/min}, and respirations are 24/min24\text{/min}. Physical examination reveals coarse crackles at the right lung base. A chest radiograph demonstrates a new right lower lobe consolidation. Endotracheal aspirate cultures grow oxidase-positive, non-lactose fermenting, Gram-negative bacilli. The patient is started on intravenous imipenem-cilastatin therapy. Initial susceptibility testing shows the isolate is susceptible to imipenem, meropenem, cefepime, and amikacin. Five days later, the patient develops a recurrent fever and worsening oxygenation. Repeat sputum cultures grow the same organism. However, this time the isolate is reported as resistant to imipenem, while remaining completely susceptible to meropenem, cefepime, and amikacin. Which of the following best describes the molecular mechanism responsible for this pathogen's acquired resistance to the prescribed therapy?

Show answer & explanation

Answer: Downregulation of a specific outer membrane diffusion channel

Answer

The mechanism responsible for the acquired isolated imipenem resistance is the downregulation or loss of a specific outer membrane diffusion channel, specifically the OprD porin.
The correct answer identifies the downregulation of a specific outer membrane diffusion channel. The clinical vignette describes a nosocomial ventilator-associated pneumonia caused by Pseudomonas aeruginosa (identified by being an oxidase-positive, non-lactose fermenting Gram-negative bacillus). During treatment with imipenem, the organism developed isolated resistance to this specific drug. Imipenem enters the periplasmic space of P. aeruginosa primarily through a specific outer membrane porin channel known as OprD. Downregulation or mutational loss of this OprD porin is a classic mechanism of rapidly acquired resistance to imipenem during active therapy. Because meropenem and cefepime utilize different or multiple entry pathways and are more heavily influenced by efflux pumps, an isolated loss of OprD typically leaves the organism susceptible to these other beta-lactam agents.

Step-by-Step Solution

1
Identify the causative organism based on the provided microbiological characteristics.
The organism is an oxidase-positive, non-lactose fermenting, Gram-negative bacillus, which is characteristic of Pseudomonas aeruginosa.
Accurate identification of the pathogen is required to understand its species-specific mechanisms of antibiotic resistance.
2
Analyze the change in the antimicrobial susceptibility profile during the course of treatment.
The organism developed isolated resistance to imipenem while maintaining full susceptibility to other anti-pseudomonal beta-lactams (meropenem, cefepime) and aminoglycosides (amikacin).
Different antimicrobial agents, even within the same class (like carbapenems), are affected by different resistance mechanisms.
3
Correlate the specific susceptibility pattern with the corresponding molecular resistance mechanism in P. aeruginosa.
Imipenem relies heavily on the specific outer membrane porin OprD to enter the periplasmic space. Downregulation or loss of OprD causes isolated imipenem resistance.
Meropenem and cefepime are less reliant on OprD for cellular entry, explaining why they remain susceptible despite the acquired resistance to imipenem.

Key Concept

Infection with Pseudomonas aeruginosa can result in the rapid development of isolated imipenem resistance during therapy due to the mutational loss or downregulation of the OprD outer membrane porin channel.
Question 66Question →

A 42-year-old man presents to the clinic for a follow-up regarding progressive shortness of breath and a persistent, productive cough over the past 8 months. He has no history of smoking, though he worked as a bartender in poorly ventilated spaces for several years. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 128/82 mmHg, heart rate of 78/min, and respiratory rate of 18/min. Physical examination reveals diminished breath sounds in all lung fields, most prominently at the lung bases, and a firm liver edge palpable 3 cm below the right costal margin. Laboratory studies reveal:

Alanine aminotransferase (ALT): 92 U/L
Aspartate aminotransferase (AST): 85 U/L
Alkaline phosphatase (ALP): 110 U/L
Total bilirubin: 1.1 mg/dL

Serum protein electrophoresis demonstrates a significantly flattened alpha-1 peak. Pulmonary function testing shows an FEV1/FVC ratio of 62% that does not improve with albuterol. A percutaneous liver biopsy reveals structurally intact lobules with prominent periportal hepatocytes containing globular, eosinophilic cytoplasmic inclusions that are strongly periodic acid-Schiff (PAS) positive and resist diastase digestion. Which of the following cellular processes is the primary mechanism directly responsible for the hepatic histopathologic findings seen in this patient?

Show answer & explanation

Answer: Accumulation of misfolded glycoproteins within the rough endoplasmic reticulum

Answer

Accumulation of misfolded glycoproteins within the rough endoplasmic reticulum
The patient's clinical presentation of early-onset obstructive lung disease, hepatomegaly, and a flattened alpha-1 peak on serum protein electrophoresis indicates Alpha-1 antitrypsin (AAT) deficiency. The classic hepatic histopathology of AAT deficiency demonstrates periportal, eosinophilic, round cytoplasmic inclusions that are periodic acid-Schiff (PAS) positive and resist digestion by diastase. AAT is a glycoprotein primarily synthesized in the liver. The most common severe genetic variant, the PiZ allele, results in a single amino acid substitution that causes the nascent AAT protein to misfold. Because it is misfolded, it cannot be effectively transported from the rough endoplasmic reticulum (RER) to the Golgi apparatus. Consequently, the misfolded glycoproteins accumulate and polymerize within the RER. This massive accumulation dilates the RER cisternae (forming the visible globules), induces endoplasmic reticulum stress, and ultimately leads to hepatocyte apoptosis and liver cirrhosis.

Step-by-Step Solution

1
Synthesize the clinical presentation and laboratory findings to establish a diagnosis.
The combination of early-onset basilar-predominant emphysema in a non-smoker, hepatomegaly, a flattened alpha-1 peak on serum protein electrophoresis, and PAS-positive, diastase-resistant hepatic inclusions is pathognomonic for Alpha-1 antitrypsin (AAT) deficiency.
Accurate disease identification is the prerequisite for understanding its dual pathophysiologic mechanisms.
2
Differentiate the mechanism of injury in the lungs versus the liver for this specific disease.
Lung injury is caused by a loss of function (lack of functional AAT to inhibit neutrophil elastase), whereas liver injury is caused by a toxic gain of function (intracellular accumulation of the abnormal protein).
The question specifically asks for the mechanism responsible for the hepatic histopathologic findings, requiring the exclusion of the pulmonary mechanism.
3
Identify the exact subcellular location and process underlying the hepatic inclusions.
The mutation (most commonly PiZZ) alters the AAT protein structure, preventing it from properly folding and migrating from the rough endoplasmic reticulum (RER) to the Golgi apparatus. The misfolded glycoproteins aggregate in the RER, creating the characteristic eosinophilic globules and causing cellular injury via ER stress.
This confirms that RER accumulation is the direct cause of the biopsy findings.

Key Concept

Intracellular accumulation of misfolded proteins as a mechanism of cellular injury.
Estimated Time:2m 0s
Question 67Question →

A 50-year-old woman is admitted to the cardiac intensive care unit for management of recurrent, hemodynamically stable ventricular tachycardia. The medical team initiates a continuous intravenous infusion of a novel antiarrhythmic medication. The pharmacology profile of this new drug indicates a volume of distribution (VdV_d) of 100100 L and a systemic clearance (CLCL) of 1010 L/hr. The drug follows first-order elimination kinetics. Assuming no loading dose is administered, approximately how long will it take for the drug to reach 94%94\% of its steady-state plasma concentration?

Show answer & explanation

Answer: 28 hours

Answer

28 hours
The time required to reach a steady-state plasma concentration during a continuous intravenous infusion is determined exclusively by the drug's elimination half-life (t1/2t_{1/2}). First, calculate the half-life using the pharmacokinetic formula t1/2=0.7×VdCLt_{1/2} = \frac{0.7 \times V_d}{CL}. Substituting the given values yields t1/2=0.7×10010=7t_{1/2} = \frac{0.7 \times 100}{10} = 7 hours. Under first-order kinetics, drug accumulation is exponential: it takes one half-life to reach 50%50\% of steady state, two to reach 75%75\%, three to reach 87.5%87.5\%, and four to reach 93.75%93.75\% (which rounds to 94%94\%). Therefore, it requires 4×7=284 \times 7 = 28 hours to achieve the target concentration.

Step-by-Step Solution

1
Calculate the elimination half-life of the drug.
t1/2=0.7×100 L10 L/hr=7 hourst_{1/2} = \frac{0.7 \times 100 \text{ L}}{10 \text{ L/hr}} = 7 \text{ hours}
The time to reach steady state is dependent entirely on the drug's half-life.
2
Determine the number of half-lives required to reach approximately 94% of steady state.
4 half-lives
The approach to steady state follows an exponential curve: 1 half-life = 50%, 2 = 75%, 3 = 87.5%, 4 = 93.75% (approximately 94%).
3
Calculate the total time required.
4×7 hours=28 hours4 \times 7 \text{ hours} = 28 \text{ hours}
Multiply the calculated half-life by the number of half-lives required to reach the target concentration.

Key Concept

The time to reach steady-state plasma concentration depends solely on the drug's elimination half-life (t1/2t_{1/2}). It reliably takes 4 to 5 half-lives to reach a clinically relevant steady state (≥94%\geq 94\%).
Question 68Question →

A 24-year-old man who recently emigrated from a region with low vaccination coverage presents to the emergency department with a 3-day history of severe sore throat, low-grade fever, and neck swelling. Physical examination reveals a tightly adherent, grayish-white pseudomembrane over the tonsils and posterior pharynx that bleeds slightly when manipulated. He also exhibits prominent bilateral cervical lymphadenopathy. A diagnosis of respiratory diphtheria is suspected, and appropriate therapy is initiated. Arrange the following steps in chronological order to describe the cellular mechanism of action for the primary virulence factor responsible for this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the mechanism of action of the diphtheria toxin begins with receptor binding, followed by endocytosis, endosomal acidification, A subunit translocation, and finally ADP-ribosylation of elongation factor-2.
The correct sequence accurately reflects the biological cascade of the diphtheria A-B exotoxin. First, the B subunit binds to the host cell's HB-EGF receptor. This triggers receptor-mediated endocytosis. The acidic environment of the resulting endosome then causes a conformational change, allowing the B subunit to form a pore in the endosomal membrane. The A subunit is translocated through this pore into the cytoplasm, where it catalyzes the ADP-ribosylation of EF-2, definitively halting cellular protein synthesis and causing cell death.

Step-by-Step Solution

1
Identify the infectious organism from the clinical vignette.
The patient has a Corynebacterium diphtheriae infection.
The patient's unimmunized status, 'bull neck' lymphadenopathy, and a bleeding grayish-white pseudomembrane are classic findings for respiratory diphtheria.
2
Identify the primary virulence factor.
The primary virulence factor is the diphtheria toxin, a classic A-B exotoxin.
The clinical manifestations of diphtheria and its systemic complications are primarily toxin-mediated rather than caused by direct bacterial tissue invasion.
3
Determine the chronological sequence of the A-B exotoxin cellular mechanism.
Receptor binding -> Endocytosis -> Acidification/Insertion -> Translocation -> ADP-ribosylation.
This is the established cellular pathway by which the toxin gains entry to the host cell and exerts its cytotoxic effect.

Key Concept

Diphtheria toxin is an A-B exotoxin that enters host cells via receptor-mediated endocytosis and causes cell death by ADP-ribosylating elongation factor-2 (EF-2), thereby inhibiting protein synthesis.
Question 69Question →

An adult male, aged 4848 years, is evaluated in the outpatient clinic for a 66-month history of progressive fatigue, decreased libido, and arthralgias affecting the second and third metacarpophalangeal joints of both hands. He has no prior medical conditions and takes no medications. He reports drinking 11 to 22 glasses of wine on weekends. Vital signs are within normal limits. Physical examination reveals mildly hyperpigmented skin on sun-exposed areas and a palpable liver edge 22 cm below the right costal margin. There is no splenomegaly.

Laboratory studies show:
Hemoglobin: 15.215.2 g/dL
Platelet count: 210,000210,000/mm 3^3
Aspartate aminotransferase (AST): 5858 U/L
Alanine aminotransferase (ALT): 6565 U/L
Fasting transferrin saturation: 75%75\% (Normal: 2020-50%50\%)
Serum ferritin: 1,3501,350 ng/mL (Normal: 2020-250250 ng/mL)

Targeted molecular diagnostic testing confirms that the patient is homozygous for a C282Y missense mutation. Which of the following statements best characterizes the molecular mechanism and the appropriate diagnostic approach for this patient's underlying condition?

Show answer & explanation

Answer: The mutation impairs the cell surface localization of a regulatory protein, resulting in decreased hepcidin synthesis and necessitating evaluation for systemic complications.

Answer

The mutation impairs the cell surface localization of a regulatory protein, resulting in decreased hepcidin synthesis and necessitating evaluation for systemic complications.
The patient has hereditary hemochromatosis, most commonly caused by a homozygous C282Y missense mutation in the HFE gene. The HFE protein normally binds to the transferrin receptor to regulate iron absorption. The mutation causes protein misfolding and prevents its proper localization to the cell surface. This loss of function leads to a false intracellular signal of low iron stores, resulting in decreased synthesis of hepcidin by the liver. Low hepcidin levels cause uninhibited ferroportin activity on the basolateral surface of enterocytes, leading to excessive iron absorption. Because iron accumulation systemically affects the liver, pancreas, heart, and pituitary gland, patients must be comprehensively evaluated for systemic complications such as diabetes mellitus, cardiomyopathy, and hypogonadism.

Step-by-Step Solution

1
Identify the patient's underlying diagnosis based on the clinical presentation and laboratory findings.
The combination of fatigue, arthralgias in the 2nd/3rd metacarpophalangeal joints, skin hyperpigmentation, elevated transferrin saturation (75%75\%), markedly elevated ferritin (1,3501,350 ng/mL), and a homozygous C282Y mutation confirms the diagnosis of Hereditary Hemochromatosis.
Recognizing the disease is the essential first step before evaluating its specific molecular pathophysiology.
2
Determine the specific molecular consequence of the C282Y mutation in the HFE gene.
The mutation prevents proper folding and cell surface localization of the HFE protein. This disrupts its interaction with the transferrin receptor, causing a false signal of low systemic iron and consequently suppressing hepcidin production by the liver.
Understanding the exact molecular defect bridges the foundational science to the clinical presentation.
3
Relate the molecular defect to the appropriate clinical management approach.
Deficient hepcidin leads to uninhibited iron absorption and systemic deposition. Therefore, the physician must evaluate the patient for systemic complications such as diabetes mellitus, cardiomyopathy, and hypogonadism.
The question asks for both the molecular mechanism and the appropriate diagnostic approach to ensure comprehensive patient care.

Key Concept

Molecular Pathophysiology of Hereditary Hemochromatosis (HFE gene mutation)
Estimated Time:1m 30s
Question 70Question →

Match each pharmacokinetic characteristic or clinical scenario to its primary effect on a drug's pharmacokinetic parameters.

Click a left item, then click its matching right item

Items

Extensive first-pass hepatic metabolism
Extensive binding to peripheral tissue proteins
End-stage renal disease (for a renally excreted drug)
Co-administration with a cytochrome P450 inducer

Matches

Show answer & explanation

Answer

Extensive first-pass hepatic metabolism decreases oral bioavailability. Extensive binding to peripheral tissue proteins increases apparent volume of distribution. End-stage renal disease prolongs elimination half-life. Co-administration with a cytochrome P450 inducer increases hepatic clearance.
Each pharmacokinetic principle governs a specific aspect of a drug's life cycle in the body. First-pass metabolism directly limits systemic entry (bioavailability). Tissue binding pulls the drug from the measurable plasma compartment, expanding its apparent volume of distribution. Organ dysfunction (like renal failure) impairs clearance, which mathematically prolongs the half-life. Finally, enzyme induction accelerates hepatic metabolism, thereby increasing hepatic clearance.

Step-by-Step Solution

1
Analyze the effect of first-pass hepatic metabolism
Matches with decreased oral bioavailability
Metabolism in the gut wall and liver immediately after absorption reduces the active drug reaching systemic circulation.
2
Analyze the effect of extensive peripheral tissue binding
Matches with increased apparent volume of distribution
Movement of drug out of the plasma into tissues makes it appear as though the drug is distributed in a larger volume.
3
Analyze the effect of end-stage renal disease
Matches with prolonged elimination half-life
Reduced glomerular filtration rate (GFR) impairs the clearance of renally excreted drugs, causing them to accumulate and extending their half-life.
4
Analyze the effect of a cytochrome P450 inducer
Matches with increased hepatic clearance
Inducers upregulate hepatic enzymes, increasing their capacity to metabolize and clear specific drugs from the system.

Key Concept

Core pharmacokinetic parameters (bioavailability, volume of distribution, half-life, clearance) and the clinical/physiologic factors that alter them.
Question 71Question →

A 55-year-old man undergoes a screening colonoscopy, which reveals a 2-cm polyp in the descending colon. Biopsy shows a tubulovillous adenoma with high-grade dysplasia. The patient is scheduled for a polypectomy. The development of such lesions into invasive adenocarcinoma typically follows a well-characterized stepwise accumulation of genetic and epigenetic alterations.

Arrange the following molecular events in the typical chronological order of the classic adenoma-carcinoma sequence in colorectal cancer, from earliest (first) to latest (last).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

1. Biallelic loss of the APC tumor suppressor gene, 2. Activating mutation of the KRAS proto-oncogene, 3. Inactivation of the TP53 tumor suppressor gene
The correct chronological sequence of genetic alterations in the classic adenoma-carcinoma pathway is APC loss, followed by KRAS mutation, and finally TP53 inactivation. This stepwise progression correlates with the transition from normal epithelium to early adenoma, late adenoma, and eventually invasive adenocarcinoma.

Step-by-Step Solution

1
Identify the underlying biological pathway being tested based on the clinical scenario.
The scenario describes the progression of a colonic adenoma to adenocarcinoma, pointing to the classic adenoma-carcinoma sequence.
Recognizing the pathway is necessary to determine the specific genetic mutations involved.
2
Recall the first major genetic alteration in this pathway.
The initiating event is the loss of the APC tumor suppressor gene.
APC loss leads to decreased beta-catenin degradation, promoting the initial hyperproliferation of the normal epithelium into an early adenoma.
3
Determine the subsequent genetic alterations that drive progression and eventual malignancy.
KRAS mutation follows APC loss, leading to intermediate adenoma formation. Finally, TP53 inactivation occurs late, causing malignant transformation.
This specific stepwise accumulation of mutations (APC -> KRAS -> TP53) characterizes the transition from normal mucosa to invasive carcinoma.

Key Concept

The classic adenoma-carcinoma sequence in colorectal cancer involves a specific chronological accumulation of genetic mutations: APC loss (tumor initiation), KRAS mutation (adenoma progression), and TP53 inactivation (malignant transformation).
Estimated Time:45s
Question 72Question →

Match each clinical pharmacokinetic scenario with its primary underlying mechanistic consequence.

Click a left item, then click its matching right item

Items

Adding rifampin to the regimen of a patient stabilized on apixaban
Prescribing probenecid to prolong the therapeutic effect of a penicillin antibiotic
Initiating oral propranolol in a patient with Child-Pugh class C cirrhosis
Taking over-the-counter calcium carbonate simultaneously with oral ciprofloxacin
Administering a standard dose of gentamicin to a patient with anuric renal failure

Matches

Show answer & explanation

Answer

Rifampin + apixaban results in increased clearance via CYP450 induction; Probenecid + penicillin results in decreased renal excretion via OAT inhibition; Cirrhosis + propranolol results in increased systemic bioavailability via reduced first-pass extraction; Calcium + ciprofloxacin results in decreased GI absorption via complex formation; Gentamicin + anuric renal failure results in prolonged half-life via reduced GFR.
Each clinical scenario corresponds to a specific alteration in ADME: Rifampin induces CYP enzymes (metabolism); Probenecid blocks tubular secretion (excretion); Cirrhosis impairs first-pass metabolism (absorption/metabolism); Calcium chelates quinolones (absorption); and ESRD halts glomerular filtration (excretion).

Step-by-Step Solution

1
Analyze the rifampin and apixaban interaction.
Matches with increased clearance via CYP450 induction.
Rifampin induces CYP3A4, increasing the metabolism and clearance of substrates like apixaban.
2
Analyze the probenecid and penicillin interaction.
Matches with decreased renal excretion via OAT inhibition.
Probenecid blocks the active secretion of organic anions (like beta-lactams) in the proximal tubule.
3
Evaluate the effect of cirrhosis on oral propranolol.
Matches with increased systemic bioavailability via reduced first-pass extraction.
High-extraction-ratio drugs lose their extensive first-pass metabolism in cirrhosis due to shunting and liver damage.
4
Analyze the calcium carbonate and ciprofloxacin interaction.
Matches with decreased gastrointestinal absorption via complex formation.
Cations chelate fluoroquinolones in the gut lumen, preventing absorption.
5
Evaluate the effect of anuric renal failure on gentamicin.
Matches with prolonged elimination half-life via severe reduction in GFR.
Aminoglycosides depend on GFR for elimination; without GFR, the half-life increases drastically.

Key Concept

Pharmacokinetic mechanisms altering drug absorption, distribution, metabolism, and excretion (ADME) in specific clinical scenarios.
Question 73Question →

A 24-year-old man with a strong family history of early-onset colon cancer undergoes a screening colonoscopy that reveals over 200 adenomatous polyps throughout his colon. Germline genetic testing confirms a nonsense mutation in the APC gene, establishing the diagnosis of familial adenomatous polyposis (FAP). In normal colonic epithelial cells, the wild-type APC protein acts as a critical tumor suppressor by regulating the Wnt/beta-catenin signaling cascade to prevent uncontrolled cell proliferation.

Arrange the following molecular events in the correct chronological sequence representing the normal processing of beta-catenin by the APC pathway in the absence of a Wnt ligand.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Formation of the destruction complex -> Binding of beta-catenin to the complex -> Phosphorylation of beta-catenin -> Polyubiquitination -> Degradation by the 26S proteasome.
The Wnt/beta-catenin pathway is a fundamental regulator of cellular proliferation. Without Wnt ligand stimulation, cytoplasmic beta-catenin must be kept at minimal levels to prevent it from entering the nucleus and activating oncogenes like MYC and CCND1. This suppression is achieved by the APC destruction complex. First, the complex (composed of APC, axin, CK1, and GSK-3) structurally assembles. Second, it captures free cytoplasmic beta-catenin. Third, the kinases within the complex phosphorylate specific serine and threonine residues on beta-catenin. Fourth, this phosphorylation acts as a mandatory recognition signal for the E3 ubiquitin ligase (beta-TrCP) to polyubiquitinate the protein. Finally, the ubiquitin tags direct beta-catenin to the 26S proteasome for terminal degradation.

Step-by-Step Solution

1
Determine the functional role of the APC protein in a normal colonic epithelial cell.
APC acts as a tumor suppressor by functioning as an essential structural scaffold in the Wnt/beta-catenin signaling pathway.
Understanding the baseline molecular function of the gene mutated in FAP is required to map out the signaling cascade.
2
Identify the cellular state of the Wnt pathway described in the scenario.
The scenario specifies the absence of a Wnt ligand, meaning the pathway is 'OFF' and beta-catenin must be actively destroyed to prevent uncontrolled proliferation.
The presence or absence of a Wnt ligand determines whether the destruction complex is inhibited or actively processing beta-catenin.
3
Sequence the biochemical steps of beta-catenin destruction chronologically.
The APC-axin complex first forms and binds beta-catenin. Kinases (CK1, GSK-3) then phosphorylate beta-catenin. This modification targets it for polyubiquitination, which finally directs it to the proteasome for destruction.
Biological signal transduction cascades follow a strict physical and biochemical chronology (assembly -> binding -> biochemical modification -> targeting -> execution).

Key Concept

In the absence of Wnt signaling, the APC tumor suppressor protein forms a destruction complex with axin and specific kinases to capture, phosphorylate, and ubiquitinate beta-catenin, targeting it for proteasomal degradation to prevent the expression of pro-proliferative oncogenes.
Question 74Question →

A 32-year-old woman presents to the ambulatory care clinic with a painful, fluctuant soft tissue mass on her left thigh that has been enlarging over the past four days. She has no significant past medical history. Vital signs are within normal limits. An incision and drainage are performed, yielding purulent material that is sent for microbiologic analysis. Two days later, the culture grows *Staphylococcus aureus*. Antimicrobial susceptibility testing reveals resistance to oxacillin and erythromycin, but the isolate is initially reported as susceptible to clindamycin. The laboratory performs an additional disk diffusion assay by placing the erythromycin and clindamycin disks adjacent to each other on the agar plate. A distinct flattening of the clindamycin zone of inhibition adjacent to the erythromycin disk is observed. Based on these laboratory findings, the physician decides to prescribe an alternative oral antibiotic instead of clindamycin. Which of the following best describes the molecular mechanism responsible for the phenomenon observed in the adjacent disk diffusion testing?

Show answer & explanation

Answer: Post-transcriptional methylation of 23S ribosomal RNA

Answer

Post-transcriptional methylation of 23S ribosomal RNA
The clinical vignette describes a positive D-test, which identifies inducible clindamycin resistance in staphylococci. When an isolate is resistant to erythromycin but appears susceptible to clindamycin in isolated testing, it may possess an *erm* (erythromycin ribosome methylation) gene. Erythromycin acts as an inducing agent, triggering the expression of this gene. The *erm* gene encodes an enzyme that methylates the 23S rRNA component of the 50S ribosomal subunit. This methylation alters the shared binding site for Macrolides, Lincosamides (clindamycin), and Streptogramin B (MLS_B resistance phenotype), rendering clindamycin ineffective in vivo despite initial in vitro susceptibility. Because of this, clindamycin should not be used for treatment, prompting the physician to choose an alternative.

Step-by-Step Solution

1
Analyze the susceptibility profile and the special laboratory test described in the vignette.
The isolate is MRSA (oxacillin resistant) that is erythromycin-resistant and clindamycin-susceptible, but shows a blunted clindamycin zone of inhibition when placed near erythromycin (a positive D-test).
Identifying the D-test is essential to determining the specific resistance phenotype being described.
2
Correlate the positive D-test with its underlying biological mechanism.
A positive D-test indicates inducible Macrolide-Lincosamide-Streptogramin B (MLS_B) resistance.
Erythromycin acts as an inducing agent that triggers the expression of a resistance gene (erm gene) in the bacteria.
3
Identify the molecular action of the erm gene product.
The erm gene encodes an enzyme that methylates the 23S rRNA of the 50S ribosomal subunit.
This target-site alteration prevents both macrolides (erythromycin) and lincosamides (clindamycin) from binding, explaining why clindamycin would fail in vivo despite appearing susceptible in standard isolated testing.

Key Concept

Inducible clindamycin resistance (MLS_B phenotype) in staphylococci is detected by a positive D-test and is mediated by the erm gene, which causes post-transcriptional methylation of the 23S rRNA binding site.
Question 75Question →

Match each classic paraneoplastic clinical presentation with its most strongly associated primary neoplasm.

Click a left item, then click its matching right item

Items

Severe hyponatremia, low serum osmolality, and inappropriately concentrated urine
Hypercalcemia, hypophosphatemia, and suppressed intact parathyroid hormone
Erythrocytosis with an elevated hemoglobin and hematocrit in the absence of hypoxia
Episodic cutaneous flushing, secretory diarrhea, and right-sided valvular heart disease

Matches

Show answer & explanation

Answer

Severe hyponatremia matches with small cell carcinoma of the lung; hypercalcemia matches with squamous cell carcinoma of the lung; erythrocytosis matches with renal cell carcinoma; and episodic flushing/diarrhea matches with neuroendocrine tumor of the small intestine.
Each listed clinical presentation represents a classic paraneoplastic syndrome directly linked to the ectopic hormone or peptide production of its respective primary tumor. Small cell lung cancer causes SIADH (ADH), squamous cell lung cancer causes humoral hypercalcemia (PTHrP), renal cell carcinoma causes erythrocytosis (EPO), and neuroendocrine tumors cause carcinoid syndrome (Serotonin).

Step-by-Step Solution

1
Identify the paraneoplastic syndrome responsible for hyponatremia with inappropriately concentrated urine.
Recognize this as SIADH, which is most classically associated with small cell carcinoma of the lung.
Small cell lung cancer has a strong neuroendocrine differentiation capable of secreting ectopic ADH.
2
Identify the driver of hypercalcemia with suppressed intact parathyroid hormone.
Recognize this as PTHrP-mediated hypercalcemia, which maps to squamous cell carcinoma of the lung.
PTHrP acts at the same receptors as PTH, causing hypercalcemia and hypophosphatemia, but suppresses endogenous PTH.
3
Identify the mechanism of erythrocytosis without hypoxia.
Recognize this as ectopic erythropoietin (EPO) production, most commonly associated with renal cell carcinoma.
The kidneys are the primary source of EPO; malignancies of renal origin can autonomously secrete it.
4
Identify the syndrome characterized by flushing, diarrhea, and right heart lesions.
Recognize carcinoid syndrome, which is caused by vasoactive substances from a neuroendocrine tumor of the small intestine.
Serotonin secretion leads to systemic symptoms when the tumor load (often via liver metastasis) exceeds hepatic breakdown capacity.

Key Concept

Paraneoplastic Syndromes in Oncology
Question 76Question →

Match each patient's clinical presentation with the precise molecular mechanism of the responsible pathogen's primary virulence factor.

Click a left item, then click its matching right item

Items

A 6-year-old unvaccinated boy presents with a thick, grayish pharyngeal pseudomembrane and severe cervical lymphadenopathy.
A 65-year-old woman develops profuse, watery, non-bloody diarrhea with a 'rice-water' appearance after consuming undercooked seafood.
A 45-year-old man hospitalized for severe pneumonia develops cramping abdominal pain and frequent watery stools after a course of clindamycin.
A 2-month-old infant presents with severe paroxysmal coughing spells followed by a high-pitched inspiratory whoop and post-tussive emesis.
A 35-year-old landscaper presents with intense muscle spasms, trismus, and a rigid, arched back following a deep puncture wound to his foot.

Matches

Show answer & explanation

Answer

Diphtheria pairs with EF-2 ADP-ribosylation; Cholera pairs with Gs-alpha ADP-ribosylation; C. difficile pairs with Rho GTPase glycosylation; Pertussis pairs with Gi-alpha ADP-ribosylation; Tetanus pairs with SNARE protein cleavage.
Each correct pair accurately links a classic infectious disease presentation to the specific cellular mechanism of its causative exotoxin.

Step-by-Step Solution

1
Analyze each clinical vignette to diagnose the infectious disease and identify the causative pathogen.
Diagnoses identified: 1. Diphtheria (C. diphtheriae), 2. Cholera (V. cholerae), 3. C. difficile colitis (C. difficile), 4. Pertussis (B. pertussis), 5. Tetanus (C. tetani).
Accurate pathogen identification is required to determine the specific virulence factors involved.
2
Recall the major exotoxin produced by each identified pathogen and its cellular target.
Diphtheria toxin targets EF-2; Cholera toxin targets Gs-alpha; C. difficile Toxin B targets Rho GTPases; Pertussis toxin targets Gi-alpha; Tetanospasmin targets SNARE proteins.
This establishes the link between the clinical syndrome and molecular mechanism.
3
Match the pathogen to the corresponding precise molecular mechanism provided in the options.
The accurate pairs are established based on the mechanism of action of each exotoxin.
Finalizing the pairings completes the matching exercise.

Key Concept

Bacterial Exotoxins and Cellular Mechanisms
Estimated Time:1m 30s
Question 77Question →

A 5555-year-old woman with a history of severe persistent asthma presents to the emergency department with progressively worsening shortness of breath and wheezing over the past 22 days. She reports taking her prescribed oral theophylline inconsistently over the last week. On examination, she is in mild respiratory distress with diffuse bilateral expiratory wheezes. Her current serum theophylline concentration is measured at 4.0 mg/L4.0 \text{ mg/L}. The physician orders an intravenous loading dose of aminophylline to rapidly achieve a target therapeutic theophylline concentration of 12.0 mg/L12.0 \text{ mg/L}. The patient weighs 70 kg70 \text{ kg}. The population volume of distribution for theophylline is 0.5 L/kg0.5 \text{ L/kg}. Aminophylline is a water-soluble salt complex that contains 80%80\% theophylline by weight (salt factor S=0.8S = 0.8). Assuming complete bioavailability for the intravenous route, what is the appropriate loading dose of intravenous aminophylline required to reach the target concentration?

Show answer & explanation

Answer: 350

Answer

350
The required supplemental loading dose is calculated using the formula: Loading Dose=Vd×(Ctarget−Ccurrent)S×F\text{Loading Dose} = \frac{V_d \times (C_{target} - C_{current})}{S \times F}. First, the volume of distribution (VdV_d) is calculated as 35 L35 \text{ L} (70 kg×0.5 L/kg70 \text{ kg} \times 0.5 \text{ L/kg}). Next, the required change in concentration is 8.0 mg/L8.0 \text{ mg/L} (12.0 mg/L−4.0 mg/L12.0 \text{ mg/L} - 4.0 \text{ mg/L}). The mass of active theophylline needed is 35 L×8.0 mg/L=280 mg35 \text{ L} \times 8.0 \text{ mg/L} = 280 \text{ mg}. Since the medication being given is aminophylline (which is 80%80\% theophylline, meaning the salt factor S=0.8S = 0.8) via the intravenous route (bioavailability F=1.0F = 1.0), the total dose of aminophylline required is 280 mg/0.8=350 mg280 \text{ mg} / 0.8 = 350 \text{ mg}.

Step-by-Step Solution

1
Calculate the volume of distribution (VdV_d) for the patient.
Vd=0.5 L/kg×70 kg=35 LV_d = 0.5 \text{ L/kg} \times 70 \text{ kg} = 35 \text{ L}.
The total volume into which the drug distributes is needed to calculate the total mass of drug required in the body.
2
Calculate the required change in serum drug concentration (ΔC\Delta C).
ΔC=12.0 mg/L−4.0 mg/L=8.0 mg/L\Delta C = 12.0 \text{ mg/L} - 4.0 \text{ mg/L} = 8.0 \text{ mg/L}.
Because the patient already has a subtherapeutic level of theophylline in her system, the loading dose only needs to provide the difference to reach the target concentration.
3
Calculate the total mass of theophylline required.
Required Theophylline=Vd×ΔC=35 L×8.0 mg/L=280 mg\text{Required Theophylline} = V_d \times \Delta C = 35 \text{ L} \times 8.0 \text{ mg/L} = 280 \text{ mg}.
This is the actual amount of active drug (theophylline) that must be added to the patient's system to achieve the concentration shift.
4
Convert the theophylline requirement to the aminophylline dose.
Aminophylline Dose=280 mg0.8=350 mg\text{Aminophylline Dose} = \frac{280 \text{ mg}}{0.8} = 350 \text{ mg}.
Aminophylline is a complex that is only 80%80\% theophylline by weight. Therefore, a proportionally larger total mass of aminophylline must be administered to deliver the required active amount of theophylline.

Key Concept

Calculation of a supplemental loading dose requires determining the target change in concentration (ΔC\Delta C) and accounting for both the volume of distribution (VdV_d) and the salt factor (SS) of the administered drug formulation.
Question 78Question →

A 62-year-old woman is diagnosed with invasive ductal carcinoma of the breast. Pathologic evaluation reveals distant metastasis to the bone. To establish this distant metastasis, the neoplastic cells must have completed a series of complex biological steps known as the metastatic cascade. Arrange the following critical events of the metastatic cascade in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with cell detachment via E-cadherin downregulation, followed by basement membrane degradation via matrix metalloproteinases, intravasation into the circulation, and finally adhesion and extravasation at the distant site.
Metastasis requires a precise sequence of events. First, tumor cells lose their adhesion to each other (via loss of E-cadherin). Next, they secrete proteolytic enzymes like matrix metalloproteinases to dissolve the basement membrane. Only after breaching this barrier can they move through the interstitial connective tissue and intravasate into blood or lymphatic vessels. Finally, the surviving circulating tumor cells must adhere to the endothelium at a distant site and extravasate into the surrounding tissue to form a new tumor.

Step-by-Step Solution

1
Identify the initial requirement for cellular migration.
Downregulation of E-cadherin.
E-cadherin maintains intercellular junctions; its downregulation allows individual cells to detach from the primary tumor mass.
2
Determine the mechanism of local tissue invasion.
Secretion of matrix metalloproteinases.
Before reaching vessels, tumor cells must degrade the physical barrier of the basement membrane and extracellular matrix.
3
Identify the process of systemic dissemination.
Intravasation into the circulation.
The invading cells must penetrate the endothelium of local vessels to travel to distant sites.
4
Determine the final step for establishing a secondary colony.
Adhesion to distant endothelium and extravasation.
The circulating tumor cells must bind to the endothelium at the target organ and exit the vessel to establish a metastatic focus.

Key Concept

The metastatic cascade follows an ordered physiological sequence: cellular detachment (loss of E-cadherin), local invasion (metalloproteinases degrading the basement membrane), intravasation into the circulation, and extravasation into the target organ.
Estimated Time:1m 0s
Question 79Question →

A medical geneticist is reviewing the molecular pathophysiology of various inherited disorders to guide genetic counseling and targeted therapies. Understanding the exact nature of the genetic alteration is essential for predicting disease severity and managing systemic complications. Match the following clinical genetic disorders with their primary underlying molecular mechanism.

Click a left item, then click its matching right item

Items

Cystic fibrosis (most common allele)
Achondroplasia
Duchenne muscular dystrophy
Sickle cell anemia

Matches

Show answer & explanation

Answer

Cystic fibrosis matches with abnormal protein folding and intracellular degradation. Achondroplasia matches with constitutive activation of a transmembrane tyrosine kinase receptor. Duchenne muscular dystrophy matches with a frameshift mutation leading to a truncated protein. Sickle cell anemia matches with a missense mutation promoting abnormal protein polymerization.
Matching the correct molecular mechanisms relies on understanding the specific genetic pathogenesis of these classic disorders. Cystic fibrosis (delta F508) represents a defect in post-translational processing and intracellular trafficking. Achondroplasia represents a classic gain-of-function mutation altering receptor signaling dynamics. Duchenne muscular dystrophy is the quintessential example of an out-of-frame (frameshift) mutation leading to total loss of protein function. Sickle cell anemia is driven by a precise missense mutation that alters the physical properties of hemoglobin under hypoxic stress.

Step-by-Step Solution

1
Analyze the molecular defect in Cystic fibrosis.
Identified as a CFTR folding defect.
The delta F508 mutation deletes a single phenylalanine residue, which impairs post-translational folding, resulting in targeted proteasomal degradation.
2
Analyze the molecular defect in Achondroplasia.
Identified as FGFR3 overactivation.
A specific point mutation in the FGFR3 gene causes the receptor to be continuously active without binding to fibroblast growth factor, prematurely limiting bone growth.
3
Analyze the molecular defect in Duchenne muscular dystrophy.
Identified as an out-of-frame mutation.
Unlike the milder Becker variant (in-frame), Duchenne is caused by frameshift mutations that create premature stop codons, obliterating dystrophin function.
4
Analyze the molecular defect in Sickle cell anemia.
Identified as beta-globin chain polymerization.
The substitution of a polar amino acid for a nonpolar one (valine) creates a hydrophobic pocket that drives aggregation of deoxygenated HbS molecules.

Key Concept

Molecular pathogenesis of monogenic disorders
Estimated Time:1m 0s
Question 80Question →

A 68-year-old man with a history of heart failure with reduced ejection fraction and atrial fibrillation comes to the emergency department reporting severe nausea, vomiting, blurred vision, and seeing yellow-green halos around objects for the past two days. His medications include lisinopril, metoprolol succinate, furosemide, and digoxin. Two weeks ago, oral amiodarone was added to his regimen by his cardiologist for recurrent, symptomatic atrial fibrillation. His pulse is 48/min and blood pressure is 110/70 mm Hg. An electrocardiogram shows sinus bradycardia with first-degree atrioventricular block. Laboratory studies show:

Serum potassium: 4.1 mEq/L4.1 \text{ mEq/L}
Serum creatinine: 1.1 mg/dL1.1 \text{ mg/dL}
Serum digoxin: 3.4 ng/mL3.4 \text{ ng/mL} (therapeutic range: 0.50.5 to 2.0 ng/mL2.0 \text{ ng/mL})

Which of the following pharmacokinetic mechanisms best explains this patient's current presentation?

Show answer & explanation

Answer: Inhibition of P-glycoprotein-mediated drug efflux

Answer

Inhibition of P-glycoprotein-mediated drug efflux
The patient is exhibiting classic signs of digoxin toxicity (nausea, vomiting, visual changes, bradycardia, and first-degree AV block) precipitated by the recent addition of amiodarone. Amiodarone is a potent inhibitor of P-glycoprotein (P-gp), an efflux transporter located in the intestinal mucosa, renal proximal tubules, and biliary system. Digoxin is a primary substrate for P-gp. Inhibition of P-gp by amiodarone reduces the renal and biliary clearance of digoxin and increases its intestinal absorption, leading to elevated serum digoxin levels and subsequent toxicity. Because of this interaction, the dose of digoxin should typically be reduced by 50% when amiodarone is initiated.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has nausea, visual disturbances, bradycardia, AV block, and an elevated serum digoxin level (3.4 ng/mL3.4 \text{ ng/mL}), confirming digoxin toxicity.
Identifying the active clinical problem is the first step to determining its etiology.
2
Identify the precipitating factor for the toxicity.
The recent addition of amiodarone to a stable digoxin regimen is the precipitating event.
Amiodarone is known to have significant drug-drug interactions that can rapidly alter the pharmacokinetics of concurrent medications.
3
Determine the specific pharmacokinetic mechanism of the interaction.
Amiodarone inhibits P-glycoprotein, decreasing digoxin clearance and increasing its levels.
Understanding the specific transporter involved in the amiodarone-digoxin interaction is required to answer the question.

Key Concept

Amiodarone causes digoxin toxicity by inhibiting P-glycoprotein (P-gp), which decreases the renal and biliary clearance of digoxin and increases its intestinal absorption.
PreviousPage 4 / 22Next
Foundational Science and Mechanisms of Disease Practice Questions — USMLE Step 3 — Page 4 | Examkin